Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jan 28 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Metronidazole Vaginal Gel, 0.75%".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases